Duality Advisers’s Quest Diagnostics DGX Stock Holding History

Duality Advisers’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,613	Closed	-$2.43M	–	628
2023 Q4	$2.43M	Buy	+17,613	New	+$2.32M	0.26%	137
2021 Q1	–	Sell	-34,452	Closed	-$4.11M	–	561
2020 Q4	$4.11M	Buy	+34,452	New	+$4.2M	0.31%	80
2020 Q1	–	Sell	-25,482	Closed	-$2.72M	–	85
2019 Q4	$2.72M	Sell	25,482 -9,098	-26%	-$949K	0.16%	178
2019 Q3	$3.7M	Buy	34,580 +21,960	+174%	+$2.25M	0.21%	154
2019 Q2	$1.28M	Sell	12,620 -57,030	-82%	-$5.48M	0.11%	174
2019 Q1	$6.26M	Sell	69,650 -12,470	-15%	-$1.08M	0.37%	74
2018 Q4	$6.84M	Buy	+82,120	New	+$7.7M	0.4%	69

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Duality Advisers's DGX Position: Q1 2024 in Review

Duality Advisers sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 17,613 shares — an estimated $2.43M sold.

Duality Advisers first reported a position in DGX in Q4 2018 and held it in 7 quarters. The position peaked at $6.84M in Q4 2018. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Duality Advisers reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
Duality Advisers sold 17,613 Quest Diagnostics shares in Q1 2024, an estimated $2.43M.
Duality Advisers first reported a position in Quest Diagnostics in Q4 2018 and held it in 7 quarters.
Duality Advisers's Quest Diagnostics position peaked at $6.84M in Q4 2018.
818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Duality Advisers's 13F filing for Q1 2024, filed 6 May 2024.